Therpy of insulin-requiring type 2 diabetes: Potential interest of the association insulin-oral antidiabetic drugs;Traitement du diabète de type II insulino-requérant : Intérêt potentiel de l'association insuline-antidiabétiques oraux

Medecine et Hygiene

Volumn 54, Issue 2127, 1996, Pages 1470-1471

  Scheen, A J ^a   Paquot, N ^a   Castillo, N J ^a   Lefebvre P J ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

DRUG MECHANISM; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; SHORT SURVEY;

EID: 0029788901     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lefèbvre PJ, Scheen AJ. Management of non-insulin-dependent diabetes mellitus. Drugs 1992 ; 44 (Suppl. 3) : 29-38.
2. Genuth S. Insulin use in NIDDM. Diabetes Care 1990 ; 13 : 1240-64.
3. Turner RC, Holman RR. Insulin use in NIDDM. Rationale based on pathophysiology of disease. Diabetes Care 1990 ; 13 : 1011-20.
4. Scheen AJ, Castillo MJ, Lefèbvre PJ. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes. Acta Clin Belg 1993 ; 48 : 259-68.
5. Quatraro A, Giugliano D. The combination of insulin and oral hypoglycaemic drugs : A continuous challenge. Diabete Metab 1993 ; 19 : 219-24.
6. Castillo M, Scheen A, Paolisso G, Lefèbvre P. The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of significant residual insulin secretion. Acta Endocrinol (Copenh) 1987 ; 116 : 364-72.
7. Scheen AJ, Lefèbvre PJ. Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas. Diabetes Res Clin Pract 1989 ; 6 : S33-S43.
8. Johnson JL, Wolf SL, Kabadi UM. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Arch Intern Med 1996 ; 156 : 259-64.
9. Scheen A, Luyckx A, Castillo M, Lefèbvre P. Rôle thérapeutique des effets extra-pancréatiques des sulfamidés hypoglycémiants. Méd et Hyg 1985 ; 43 : 3816-20.
10. Yki-Järvinen H, Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1992 ; 327 : 1426-33.
11. Scheen AJ, Lefèbvre PJ. La metformine : des effets métaboliques aux indications thérapeutiques. Méd et Hyg 1993 ; 51 : 1993-8.
12. Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995 ; 49 : 721-49.
13. Golay A, Guillet-Dauphiné N, Fendel A, Juge C, Assal JP. The insulin-sparing effect of metformin in insulin-treated diabetic patients. Diabetes Metab Rev 1995 ; 11 (Suppl 1) : S63-S7.
14. Clissold SP, Edwards C. Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1988 ; 35 : 214-43.
15. Chiasson JL, Josse RG, Hunt JA, et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 1994 ; 121 : 928-35.